PreprintLicence not statedChemRxiv
A Vanadium(II) Photosensitizer Delivered by Human Serum Albumin for Photodynamic Therapy
4 affiliations
- 1Faculty of Medicine, Ruhr University Bochum, Universitätsstrasse 150, Bochum, Germany, 44801
- 2Center for Protein Diagnostics (PRODI, Ruhr University Bochum, Gesundheitscampus 4, Bochum, Germany, 44801
- 3Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Universitätsstrasse 150, Bochum, Germany, 44780
- 4Department of Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, Mainz, Germany, 55128
Versions
Related
- Reducing photosensitizer aggregation via cyclodextrin-adamantane porphyrin host-guest interactions for enhanced photodynamic therapy.
- Tumor Microenvironment-Triggered Dual-Prodrug Nanoplatform for Augmented Photodynamic Therapy: Self-Quenched Photosensitizer Activation and Nitric Oxide-Mediated Sensitization
- Programmable aggregation of photosensitizer in multi- organelles for cancer therapy
- A Latent DNA–Protein Cross-Link Agent as a Chemical Adjuvant for Photodynamic Therapy
- Unlocking the Potential of Ommatins as Sustainable Photosensitizers for Photodynamic Therapy
BibTeX
@misc{papadopoulos2026vanadiumii,
title = {{A Vanadium(II) Photosensitizer Delivered by Human Serum Albumin for Photodynamic Therapy}},
author = {Zisis Papadopoulos and Aimée Marie Irgel and Alexandra König and Katja Heinze and Johannes Karges},
howpublished = {ChemRxiv},
year = {2026},
month = sep,
doi = {10.26434/chemrxiv.15009120/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009120/v1},
}
RIS
TY - UNPB
TI - A Vanadium(II) Photosensitizer Delivered by Human Serum Albumin for Photodynamic Therapy
AU - Zisis Papadopoulos
AU - Aimée Marie Irgel
AU - Alexandra König
AU - Katja Heinze
AU - Johannes Karges
PY - 2026
DA - 2026/09/21
PB - ChemRxiv
DO - 10.26434/chemrxiv.15009120/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009120/v1
ER -